Testosterone, SHBG and differential white blood cell count in middle-aged and older men

Maturitas

Volumn 71, Issue 3, 2012, Pages 274-278

  Brand, Judith S ^a   Van Der Schouw, Yvonne T ^a   Dowsett, Mitch ^b   Folkerd, Elizabeth ^b   Luben, Robert N ^c   Wareham, Nicholas J ^d   Khaw, Kay Tee ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

SHBG; Testosterone; White blood cell count

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SMOKING; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84856971317     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.12.007     Document Type: Article

References (35)

1. W.B. Kannel, D. McGee, and T. Gordon A general cardiovascular risk profile: the Framingham study Am J Cardiol 38 1976 46 51
2. M. Muller, Y.T. van der Schouw, J.H. Thijssen, and D.E. Grobbee Endogenous sex hormones and cardiovascular disease in men J Clin Endocrinol Metab 88 2003 5076 5086 (Pubitemid 37452697)
3. A.E. Hak, J.C. Witteman, F.H. de Jong, M.I. Geerlings, A. Hofman, and H.A. Pols Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study J Clin Endocrinol Metab 87 2002 3632 3639 (Pubitemid 34879505)
4. K.T. Khaw, M. Dowsett, and E. Folkerd Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) prospective population study Circulation 116 2007 2694 2701 (Pubitemid 350291241)
5. B.B. Yeap, Z. Hyde, and O.P. Almeida Lower testosterone levels predict incident stroke and transient ischemic attack in older men J Clin Endocrinol Metab 94 2009 2353 2359
6. S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, and M.R. Blackman Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86 2001 724 731 (Pubitemid 32207487)
7. L. Ferrucci, A. Corsi, and F. Lauretani The origins of age-related proinflammatory state Blood 105 2005 2294 2299 (Pubitemid 40387022)
8. B. Tengstrand, K. Carlstrom, and I. Hafstrom Gonadal hormones in men with rheumatoid arthritis - from onset through 2 years J Rheumatol 36 2009 887 892
9. S. Khosla, E.J. Atkinson, C.R. Dunstan, and W.M. O'Fallon Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men J Clin Endocrinol Metab 87 2002 1550 1554 (Pubitemid 34615237)
10. J.S. Rana, S.M. Boekholdt, and P.M. Ridker Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk prospective population study J Intern Med 262 2007 678 689 (Pubitemid 350135192)
11. J.G. Wheeler, M.E. Mussolino, R.F. Gillum, and J. Danesh Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals Eur Heart J 25 2004 1287 1292 (Pubitemid 38998504)
12. R.C. Travis, T.J. Key, and N.E. Allen Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition Int J Cancer 121 2007 1331 1338 (Pubitemid 47293802)
13. Coulter MD series reference manual 1993 Coulter Corporation Miami, FL p. 1-98
14. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672 (Pubitemid 30645223)
15. D.E. Laaksonen, L. Niskanen, and K. Punnonen Sex hormones, inflammation and the metabolic syndrome: population-based study Eur J Endocrinol 149 2003 601 608 (Pubitemid 38054707)
16. V. Kupelian, G.R. Chiu, A.B. Araujo, R.E. Williams, R.V. Clark, and J.B. McKinlay Association of sex hormones and C-reactive protein levels in men Clin Endocrinol (Oxf) 72 2010 527 533
17. H.R. Nakhai Pour, D.E. Grobbee, M. Muller, and Y.T. van der Schouw Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men Clin Endocrinol (Oxf) 66 2007 394 398 (Pubitemid 46239299)
18. I. Van Pottelbergh, L. Braeckman, D. De Bacquer, G. De Backer, and J.M. Kaufman Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men Atherosclerosis 166 2003 95 102 (Pubitemid 35449605)
19. M. Maggio, S. Basaria, and A. Ble Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men J Clin Endocrinol Metab 91 2006 345 347 (Pubitemid 43069161)
20. C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, and T.H. Jones The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab 89 2004 3313 3318 (Pubitemid 38951897)
21. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol (Oxf) 73 2010 602 612
22. D. Kapoor, S. Clarke, R. Stanworth, K.S. Channer, and T.H. Jones The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes Eur J Endocrinol 156 2007 595 602 (Pubitemid 46796527)
23. M.K. Ng, P.Y. Liu, and A.J. Williams Prospective study of effect of androgens on serum inflammatory markers in men Arterioscler Thromb Vasc Biol 22 2002 1136 1141 (Pubitemid 34764864)
24. H.R. Nakhai-Pour, D.E. Grobbee, M.H. Emmelot-Vonk, M.L. Bots, H.J. Verhaar, and Y.T. van der Schouw Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial Am Heart J 154 2007 1228.e1 1228.e7
25. Y.J Tang, W.J. Lee, Y.T. Chen, P.H. Liu, M.C. Lee, and W.H. Sheu Serum testosterone level and related metabolic factors in men over 70 years old J Endocrinol Invest 30 2007 451 458 (Pubitemid 47496453)
26. H.J. Schneider, C. Sievers, and J. Klotsche Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study Clin Endocrinol (Oxf) 70 2009 446 454
27. S. Kalinchenko, A. Zemlyanoy, and L.J. Gooren Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases Cardiovasc Diabetol 8 2009 19
28. A.B. Kamis, and J.B. Ibrahim Effects of testosterone on blood leukocytes in plasmodium berghei-infected mice Parasitol Res 75 1989 611 613 (Pubitemid 19205860)
29. G. Yao, J. Liang, X. Han, and Y. Hou In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen Int Immunopharmacol 3 2003 1853 1860 (Pubitemid 37421268)
30. D.P. Marin, A.P. Bolin, C. dos Santos Rde, R. Curi, and R. Otton Testosterone suppresses oxidative stress in human neutrophils Cell Biochem Funct 28 2010 394 402
31. A. Mantalaris, N. Panoskaltsis, and Y. Sakai Localization of androgen receptor expression in human bone marrow J Pathol 193 2001 361 366 (Pubitemid 32229869)
32. T. van der Poll, J.A. Romijn, E. Endert, and H.P. Sauerwein Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men Metabolism 42 1993 303 307 (Pubitemid 23073346)
33. A.V. Turnbull, and C. Rivier Inhibition of gonadotropin-induced testosterone secretion by the intracerebroventricular injection of interleukin-1 beta in the male rat Endocrinology 138 1997 1008 1013 (Pubitemid 27089753)
34. J.M. Castellano, A.H. Bentsen, and M. Romero Acute inflammation reduces kisspeptin immunoreactivity at the arcuate nucleus and decreases responsiveness to kisspeptin independently of its anorectic effects Am J Physiol Endocrinol Metab 299 2010 E45 61
35. Z. Yesilova, M. Ozata, and I.H. Kocar The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism J Clin Endocrinol Metab 85 2000 66 70 (Pubitemid 32268791)